| ²é¿´: 2442 | »Ø¸´: 1 | |||
[½»Á÷]
2016ÄêаæSCI·ÖÖµÏÂÀ´ÁË ÄãͶ¸åµÄÆÚ¿¯·ÖÖµÓÐÉÏÉýÂ𣿠ÒÑÓÐ1È˲ÎÓë
|
| Äã·¢±íµÄÆÚ¿¯IF·ÖÖµÓÐûÓÐÉÏÉýÄØ£¿ |
» ±¾Ìû¸½¼þ×ÊÔ´Áбí
-
»¶Ó¼à¶½ºÍ·´À¡£ºÐ¡Ä¾³æ½öÌṩ½»Á÷ƽ̨£¬²»¶Ô¸ÃÄÚÈݸºÔð¡£
±¾ÄÚÈÝÓÉÓû§×ÔÖ÷·¢²¼£¬Èç¹ûÆäÄÚÈÝÉæ¼°µ½ÖªÊ¶²úȨÎÊÌ⣬ÆäÔðÈÎÔÚÓÚÓû§±¾ÈË£¬Èç¶Ô°æÈ¨ÓÐÒìÒ飬ÇëÁªÏµÓÊÏ䣺xiaomuchong@tal.com - ¸½¼þ 1 : 2016_new_IF½ð±à¼15979190352.xlsx
2016-06-22 11:49:20, 743.43 K
» ²ÂÄãϲ»¶
Çóµ÷¼Á0703
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸Ìì½ò´óѧ339²ÄÁÏÓ뻯¹¤Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
Ò»Ö¾Ô¸»ªÄÏʦ·¶361·Ö£¬»¯Ñ§Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
282Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
Ò»Ö¾Ô¸ ÄϾ©º½¿Õº½Ìì´óѧ £¬080500²ÄÁÏ¿ÆÑ§Ó빤³Ìѧ˶
ÒѾÓÐ10È˻ظ´
273Çóµ÷¼Á
ÒѾÓÐ13È˻ظ´
Ò»Ö¾Ô¸085600ÖпÆÔºÄþ²¨Ëù276·ÖÇóµ÷¼Á
ÒѾÓÐ21È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
339Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
265Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
alvis123xy
½û³æ
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 75
- É¢½ð: 20
- Ìû×Ó: 34
- ÔÚÏß: 30.8Сʱ
- ³æºÅ: 3822502
- ×¢²á: 2015-04-20
- רҵ: µØ´Åѧ
¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
|
Glycosylation of haptoglobin as a personalized biomarker for hepatocellular carcinoma treated with sorafenib£¬¿É·¢3£4·Ö¡£ The molecular mechanism of miR-155 targeting MMP-9 inhibition of Wnt ¦¢-catenin pathway on liver fibrosis¿É²Ù×÷µ½2·Ö¶à£¬¸Îµ¨¿Æ¿ÉÓà »·¾³¿ÆÑ§ A novel short-term PM2.5 concentration prediction model based on an artificial neural network and the cuckoo optimization algorithm Ͷ¸å¿¯ÎïÈçÏ£º£¨¶þÇø£¬3·ÖÒÔÉÏ£© Õ¾ÄÚÁªÏµ |
2Â¥2016-06-24 03:55:52














»Ø¸´´ËÂ¥